Smiths Group has agreed to sell Smiths Medical to ICU Medical for up to $2.45bn.
Smiths Medical markets syringe and ambulatory infusion devices, vascular access, and vital care products while ICU Medical focuses on infusion...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?